ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Vitamin D Metabolism and the Williams Syndrome

This study has been completed.

Sponsored by: National Center for Research Resources (NCRR)
Information provided by: National Center for Research Resources (NCRR)
ClinicalTrials.gov Identifier: NCT00013962
  Purpose

The Williams syndrome is a disease in which supravalvular aortic stenosis, an elfin facies, mental retardation and other congenital defects are sometimes associated with abnormal vitamin D and calcium metabolism. Whereas some patients have been reported to show increased sensitivity to vitamin D or an exaggerated response of serum 25-hydroxyvitamin D {25(OH)D} to administration of vitamin D and to have hypercalcemia caused by increased circulating 1,25-dihydroxyvitamin D{1,25(OH)2D} in infancy and early childhood, most patients have normal calcium metabolism and normal values for circulating 25(OH)D and 1,25(OH)2D. We propose to carry out further studies of vitamin D metabolism to elucidate the mechanism(s) for abnormal vitamin D metabolism. We will determine the response of serum 1,25(OH)2D to administration of 1,25(OH)2D3. Measurement of the 1,25(OH)2D in the patients compared to normal subjects will be the primary outcome.


Condition Intervention
Williams Syndrome
Drug: Vitamin D

Genetics Home Reference related topics:   Williams syndrome   

ChemIDplus related topics:   Vitamin D    Ergocalciferol   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Natural History, Case Control
Official Title:   Vitamin D Metabolism and the Williams Syndrome
  Eligibility
Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Age 18 years to 50 years of age, patients and normal subjects

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00013962

Locations
United States, South Carolina
Medical University of South Carolina    
      Charleston, South Carolina, United States, 29425

Sponsors and Collaborators
  More Information


Study ID Numbers:   NCRR-M01RR01070-0562
First Received:   April 3, 2001
Last Updated:   June 23, 2005
ClinicalTrials.gov Identifier:   NCT00013962
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Chromosomal abnormalities
Heart Diseases
Ergocalciferols
Chromosome Disorders
Constriction, Pathologic
Aortic valve stenosis
Heart Valve Diseases
Mental Retardation
Vitamin D
Williams Syndrome
Genetic Diseases, Inborn
Neurologic Manifestations
Aortic Valve Stenosis
Congenital Abnormalities
Neurobehavioral Manifestations
Williams syndrome

Additional relevant MeSH terms:
Pathologic Processes
Disease
Growth Substances
Vitamins
Syndrome
Physiological Effects of Drugs
Nervous System Diseases
Aortic Stenosis, Supravalvular
Bone Density Conservation Agents
Cardiovascular Diseases
Micronutrients
Pharmacologic Actions

ClinicalTrials.gov processed this record on October 07, 2008




Links to all studies - primarily for crawlers